The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Quantitative study of insulin secretion and clearance in normal and obese subjects
Open accessAbstract
The secretion and hepatic extraction of insulin were compared in 14 normal volunteers and 15 obese subjects using a previously validated mathematical model of insulin secretion and rate constants for C-peptide derived from analysis of individual decay curves after intravenous bolus injections of biosynthetic human C-peptide. Insulin secretion rates were substantially higher than normal in the obese subjects after an overnight fast (86.7 +/- 7.1 vs. 50.9 +/- 4.8 pmol/m2 per min, P less than 0.001, mean +/- SEM), over a 24-h period on a mixed diet (279.6 +/- 24.2 vs. 145.8 +/- 8.8 nmol/m2 per 24 h, P less than 0.001), and during a hyperglycemic intravenous glucose infusion (102.2 +/- 10.8 vs. 57.2 +/- 2.8 nmol/m2 per 180 min, P less than 0.001). Linear regression analysis revealed a highly significant relationship between insulin secretion and body mass index. Basal hepatic insulin extraction was not significantly different in the normal and obese subjects (53.1 +/- 3.8 vs. 51.6 +/- 4.0%). In the normal subjects, fasting insulin did not correlate with basal hepatic insulin extraction, but a significant negative correlation between fasting insulin and hepatic insulin extraction was seen in obesity (r = -0.63, P less than 0.02). This finding reflected a higher extraction in the six obese subjects with fasting insulin levels within the range of the normal subjects than in the nine subjects with elevated fasting insulin concentrations (61 +/- 3 vs. 45 +/- 6%, P less than 0.05). During the hyperglycemic clamp, the insulin secretion rate increased to an average maximum of 6.2-fold over baseline in the normal subjects and 5.8-fold in the obese subjects. Over the same time, the peripheral insulin concentration increased 14.1-fold over baseline in the normals and 16.6-fold over baseline in the obese, indicating a reduction in the clearance of endogenously secreted insulin. Although the fall in insulin clearance tended to be greater in the obese subjects, the differences between the two groups were not statistically significant. Thus, under basal, fasting conditions and during ingestion of a mixed diet, the hyperinsulinemia of obesity results predominantly from increased insulin secretion. In patients with more marked basal hyperinsulinemia and during intense stimulation of insulin secretion, a reduction in insulin clearance may contribute to the greater increase in peripheral insulin concentrations that are characteristic of the obese state.+
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The first stage of diabetes development is a long compensatory period when insulin resistance is present and accompanied by increased rates of insulin secretion44 and an increased β-cell mass.39”
From Prediabetes: a high-risk state for diabetes development (2012) · cites this paper as [44]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Robust Locally Weighted Regression and Smoothing Scatterplots
Cleveland, W. S. (1979) · Journal of the American Statistical Association · doi:10.1080/01621459.1979.10481038 · Cited by 11,594
Morgan, C. R., & Lazarow, A. (1963) · Diabetes · doi:10.2337/diab.12.2.115 · Cited by 2,197
Robust Locally Weighted Regression and Smoothing Scatterplots
Cleveland, W. S. (1979) · Journal of the American Statistical Association · doi:10.2307/2286407 · Cited by 2,063
Relation of Body Fat Distribution to Metabolic Complications of Obesity*
KISSEBAH, A. H., VYDELINGUM, N., MURRAY, R., EVANS, D. J., KALKHOFF, R. K., & ADAMS, P. W. (1982) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-54-2-254 · Cited by 1,909
C-Peptide as a Measure of the Secretion and Hepatic Extraction of Insulin: Pitfalls and Limitations
Polonsky, K. S., & Rubenstein, A. H. (1984) · Diabetes · doi:10.2337/diab.33.5.486 · Cited by 473
Self-citationPrehepatic Insulin Production in Man: Kinetic Analysis Using Peripheral Connecting Peptide Behavior*
EATON, R. P., ALLEN, R. C., SCHADE, D. S., ERICKSON, K. M., & STANDEFER, J. (1980) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-51-3-520 · Cited by 363
Polonsky, K. S., Licinio-Paixao, J., Given, B. D., Pugh, W., Rue, P., Galloway, J., Karrison, T., & Frank, B. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112308 · Cited by 359
Self-citationSplanchnic insulin metabolism in obesity. Influence of body fat distribution.
Peiris, A. N., Mueller, R. A., Smith, G. A., Struve, M. F., & Kissebah, A. H. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112758 · Cited by 346
Characterization of Seven C-peptide Antisera
FABER, O. K., Binder, C., Markussen, J., Hedïng, L. G., Naithani, V. K., Kuzuya, H., BLIX, P. M., Horwitz, D. L., & Rubenstein, A. H. (1978) · Diabetes · doi:10.2337/diab.27.1.s170 · Cited by 230
Splanchnic and renal metabolism of insulin in human subjects: a dose-response study
Ferrannini, E., Wahren, J., FABER, O. K., Felig, P., Binder, C., & DeFronzo, R. A. (1983) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1983.244.6.e517 · Cited by 214
Hepatic Removal of Insulin in Normal Man: Dose Response to Endogenous Insulin Secretion*
Eaton, R. P., Allen, R. C., & Schade, D. S. (1983) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-56-6-1294 · Cited by 150
Decreased hepatic insulin extraction in subjects with mild glucose intolerance
Bonora, E., Zavaroni, I., Coscelli, C., & BUTTURINI, U. (1983) · Metabolism · doi:10.1016/0026-0495(83)90004-5 · Cited by 150
Waldh�usl, W., Bratusch-Marrain, P. R., Gasic, S., Korn, A., & Nowotny, P. (1979) · Diabetologia · doi:10.1007/bf01235858 · Cited by 149
Decreased Insulin Removal Contributes to Hyperinsulinemia in Obesity
FABER, O. K., Christensen, K. C., Kehlet, H., Madsbad, S., & Binder, C. (1981) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-53-3-618 · Cited by 148
A Comparative Study on the Metabolism of Human Insulin and Porcine Proinsulin in Man
Sönksen, P. H., Tompkins, C. V., Srivastava, M. C., & Nabarro, J. D. N. (1973) · Clinical Science · doi:10.1042/cs0450633 · Cited by 148
Ishida, T., Chap, Z., Chou, J., Lewis, R., Hartley, C. J., Entman, M. L., & Field, J. B. (1983) · Journal of Clinical Investigation · doi:10.1172/jci111007 · Cited by 143
Kaden, M., Harding, P., & Field, J. B. (1973) · Journal of Clinical Investigation · doi:10.1172/jci107386 · Cited by 131
The Limitations to and Valid Use of C-Peptide as a Marker of the Secretion of Insulin
Polonsky, K. S., Frank, B. H., Pugh, W., Addis, A., Karrison, T. G., Meier, P., Tager, H. S., & Rubenstein, A. H. (1986) · Diabetes · doi:10.2337/diab.35.4.379 · Cited by 115
Self-citationC-peptide as a measure of the secretion and hepatic extraction of insulin. Pitfalls and limitations
Polonsky, K. S., & Rubenstein, A. H. (1984) · Diabetes · doi:10.2337/diabetes.33.5.486 · Cited by 104
Self-citationReduced Hepatic Insulin Extraction in Obesity: Relationship with Plasma Insulin Levels
Rossell, R., Gomis, R., Casamitjana, R., Segura, R., Vilardell, E., & Rivera, F. (1983) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-56-3-608 · Cited by 85
Meistas, M. T., Rendell, M., Margolis, S., & Kowarski, A. A. (1982) · Diabetes · doi:10.2337/diab.31.5.449 · Cited by 76
Meistas, M. T., Zadik, Z., Margolis, S., & Kowarski, A. A. (1981) · Diabetes · doi:10.2337/diab.30.8.639 · Cited by 73
Discrepancy Between Plasma C-Peptide and Insulin Response to Oral and Intravenous Glucose
Madsbad, S., Kehlet, H., Hilsted, J., & Tronier, B. (1983) · Diabetes · doi:10.2337/diab.32.5.436 · Cited by 69
Savage, P. J., Flock, E. V., Mako, M. E., BLIX, P. M., Rubenstein, A. H., & BENNETT, P. H. (1979) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-48-4-594 · Cited by 56
Usefulness of the Two-Compartment Open Model in Pharmacokinetics
Metzler, C. M. (1971) · Journal of the American Statistical Association · doi:10.1080/01621459.1971.10482216 · Cited by 50
Retroendocytosis of Insulin in Rat Adipocytes*
Levy, J. R., & Olefsky, J. M. (1986) · Endocrinology · doi:10.1210/endo-119-2-572 · Cited by 44
Calculation of the Systemic Delivery Rate of Insulin in Normal Man*
Polonsky, K. S., Given, B. D., PUGH, W., Licinio, J., THOMPSON, J. E., Karrison, T. G., & Rubenstein, A. H. (1986) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-63-1-113 · Cited by 43
Self-citationMeasurement using tracers of steady-state turnover and metabolic clearance of insulin in dogs
Morishima, T., Bradshaw, C., & Radziuk, J. (1985) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1985.248.2.e203 · Cited by 32
Inverse relationship of metabolic clearance rate of insulin to body mass index
Davidson, M. B., Harris, M. D., & Rosenberg, C. S. (1987) · Metabolism · doi:10.1016/0026-0495(87)90179-x · Cited by 29
Meistas, M. T., Rendell, M., Margolis, S., et al. (1982) · Diabetes · doi:10.2337/diabetes.31.5.449 · Cited by 20
Discrepancy between plasma C-peptide and insulin response to oral and intravenous glucose
Madsbad, S., Kehlet, H., Hilsted, J., et al. (1983) · Diabetes · doi:10.2337/diabetes.32.5.436 · Cited by 8
Cited by
Sorted by citations
Prediabetes: a high-risk state for diabetes development
Tabák, A. G., Herder, C., Rathmann, W., Brunner, E. J., & Kivimäki, M. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60283-9 · Cited by 2,958
The Role of Vitamin D and Calcium in Type 2 Diabetes. A Systematic Review and Meta-Analysis
Pittas, A. G., Lau, J., Hu, F. B., & Dawson-Hughes, B. F. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0298 · Cited by 2,048
Lewis, G. F., Carpentier, A. C., Adeli, K., & Giacca, A. (2002) · Endocrine Reviews · doi:10.1210/edrv.23.2.0461 · Cited by 1,370
Five stages of evolving beta-cell dysfunction during progression to diabetes
Weir, G. C., & Bonner-Weir, S. (2004) · Diabetes · doi:10.2337/diabetes.53.suppl_3.s16 · Cited by 1,126
Pi-Sunyer, X. (2002) · Obesity Surgery · doi:10.1007/bf03342140 · Cited by 828
Metadata
- Authors
- Polonsky, K. S., Given, B. D., Hirsch, L., Shapiro, E. T., Tillil, H., Beebe, C., Galloway, J. A., Frank, B. H., Karrison, T., & Van Cauter, E.
- Affiliations
- University of Chicago (US)
- Université Libre de Bruxelles (BE)
- Venue
- Journal of Clinical Investigation
- Published
- 1988-02-01
- Volume
- 81
- Issue
- 2
- Pages
- 435-441
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC329588
- OpenAlex
- W2132705610
- Cited by
- 444
- References
- 27
- Citations by year
- 2026: 3 · 2025: 5 · 2024: 1 · 2023: 9 · 2022: 18 · 2021: 17 · 2020: 9 · 2019: 12 · 2018: 14 · 2017: 24 · 2016: 19 · 2015: 24 · 2014: 13 · 2013: 21 · 2012: 20
- FWCI
- 9.68
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Eli Lilly and Company
- National Institutes of Health
- National Institute of Diabetes and Digestive and Kidney Diseases (DK-31842, DK 20595)
- National Center for Research Resources (RR-00055)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- insulin secretion, insulin clearance, hepatic insulin extraction, obesity, hyperinsulinemia, C-peptide, body mass index, hyperglycemic clamp, fasting insulin, mixed diet, insulin secretion rate, endogenous insulin secretion, type 2 diabetes risk, insulin sensitivity index
- MeSH terms
- Insulin Secretion, Blood Glucose, C-Peptide, Humans, Hyperglycemia, Insulin, Liver, Metabolic Clearance Rate, Obesity
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review